It 2005, Schmiemann et al. detected the abnormal methylation status of RASSF1A, APC, and p16 (INK4a) in patients with lung cancer; therefore, they proposed the use of methylation detection for early diagnosis of lung cancer5. Here, CDKN2A is linked to lung cancer.